InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding InMed Pharmaceuticals Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 9 | 1 | 7 | −1 |
| Shares | 303.6K | 1 | 227.0K | −76.5K (−25.2%) |
| Value | $665.2K | $2 | $240.7K | −$424.6K (−63.8%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 12,753 | $13.5K | 0.00% |
| Jane Street Group, LLC | 11,978 | $12.7K | 0.00% |
| UBS Group AG | 377 | $400 | 0.00% |
Sold out (4)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| DRW Securities, LLC | 35,865 | $78.5K |
| Virtu Financial LLC | 20,369 | $45.0K |
| Renaissance Technologies LLC | 16,800 | $36.8K |
| Thompson Davis & Co., Inc. | 10,249 | $22.4K |
Not filed for Q4 2025 yet (1)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| AllSquare Wealth Management LLC | 1 | $2 |